Jyong Biotech Ltd. Ordinary Shares
MENS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$159.66M
Close$
$-0.24
112.7% downside
Current Fair Value
112.7% downsideOvervalued by 112.7% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $159.66 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.06 |
| Beta | 2.38 |
| Outstanding Shares | 74,233,667 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -24.28 |
|---|---|
| PEG | -0.01 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.67%▲ 0.05% |
|---|---|
| Total Invested | $1.01M▲ 3.75% |
| Investors Holding | 19▲ 2.00% |
About Jyong Biotech Ltd. Ordinary Shares
27 employees
CEO: Fu-Feng Kuo
Jyong Biotech Ltd. is a Taiwanese biotechnology enterprise dedicated to the research, development, and market introduction of botanical therapeutics, specifically aimed at addressing diseases of the urinary system. Its operations are orc...